Labeling lipids and playing piano
For Jeremy Baskin, learning a new arrangement on the piano isn’t so different from tagging and tracking phospholipids.
“When you play the piano, and you want to learn a hard passage, you have to do it slowly. And you have to do it over and over again to get the muscle memory correct,” said Baskin, a professor at Cornell University’s Weill Institute for Cell and Molecular Biology and department of chemistry and chemical biology. “That’s a good preparation for laboratory research, where you often have to repeat experiments and change variables in order to get it to work just right.”
For about a decade of getting his work right, Baskin has been selected to receive the American Society for Biochemistry and Molecular Biology’s 2020/2021 Walter Shaw Young Investigator Award in Lipids.
He grew up in Montreal in a family with an artistic bent — both his parents are classical musicians, and his younger sister is now an actress. When he pursued chemistry as an undergraduate at the Massachusetts Institute of Technology, he found relaxation and camaraderie among fellow musicians.
“It being MIT, it wasn’t populated with a bunch of future professional musicians,” he said. “There was a lot of energy and focus on science and engineering majors that were doing music on the side.”
In 2004, Baskin joined Carolyn Bertozzi’s lab at the University of California, Berkeley, where he began developing chemical tools for imaging cell-surface glycans. In 2009, he took a postdoctoral fellowship in the lab of Pietro De Camilli at Yale University, where he narrowed his focus on membrane biology and lipid metabolism.
Baskin’s lab primarily focuses on two types of phospholipids that represent extremes in terms of size: phosphatidic acids, which have tiny headgroups, and phosphoinositides, which have massive headgroups. The lab recently has been focusing on phospholipase D, a precursor to several cancer-associated phosphatidic acids that often is upregulated in cancer.
Studying in a rich playground
Jeremy BaskinJeremy Baskin’s lab at Cornell University constantly is working on new tools to interrogate phospholipase D, an enzyme upregulated in a wide swath of cancers.
“There’s a push in other academic laboratories to develop selective inhibitors of phospholipase D for the purpose of downregulating the proliferation of cells, which is a hallmark of cancer,” Baskin said. “In the phosphatidic acid area, we’ve really focused much of our energy on the development of tools.”
In his award lecture at the 2020 ASBMB annual meeting, Baskin will speak about recently developed lipid imaging methods.
“These enzymes are, I think, a really rich playground for a chemical biologist to operate in, because they have a relaxed specificity that it allows us to come in with synthetic probes and trick the enzyme into accepting our synthetic probes instead of their natural substrates. And that is the key that allows us to develop our imaging tools,” Baskin said.
“We’re currently using them to uncover how the phospholipase D enzymes and the phosphatidic acid lipids that they produce regulate fundamental cell signaling and disease-associated signaling.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
He will receive three years of funding to support his thesis research.

Bibel named assistant professor
She began her position at Loyola Marymount University in August 2025.

Unraveling the language of histones
Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

Cotruvo named Blavatnik award finalist
He received a $15,000 prize and was honored at a gala in October.

Phosphatases and pupils: A dual legacy
Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.